The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders

Gerwyn Morris; Basant K. Puri; Chiara C. Bortolasci; André F. Carvalho; Michael Berk; Ken Walder; Estefânia Gastaldello Moreira; Michael Maes

doi:10.1016/j.neubiorev.2021.02.037

Article2007

Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese

Kuo‐Liong Chien, Hsiu‐Ching Hsu, Ta‐Chen Su, Yung‐Ming Chen, Yuan‐Teh Lee, Frank B Hu

Article2011

Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease

Gang Hu, Yadong Cui, Pekka Jousilahti, Jouko Sundvall, Cynthia J. Girman, Riitta Antikaínen, Tiina Laatikainen, Jaakko Tuomilehto

European Journal of Preventive Cardiology

Article1996

Plasma high-density lipoprotein cholesterol but not apolipoprotein A-I is a good correlate of the visceral obesity—insulin resistance dyslipidemic syndrome

Charles Couillard, Benoı̂t Lamarche, André Tchernof, Denis Prud’homme, Angelo Tremblay, Claude Bouchard, Sital Moorjanit, André Nadeau, Paul J. Lupien, Jean‐Pierre Després

Metabolism

Article2013

Genomic, Transcriptomic, and Lipidomic Profiling Highlights the Role of Inflammation in Individuals With Low High-density Lipoprotein Cholesterol

Pirkka‐Pekka Laurila, Ida Surakka, Antti‐Pekka Sarin, Laxman Yetukuri, Tuulia Hyötyläinen, Sanni Söderlund, Jussi Naukkarinen, Jing Tang, Johannes Kettunen, Daniel B. Mirel, Jarkko Soronen, Terho Lehtimäki, Aimo Ruokonen, Christian Ehnholm, Johan G. Eriksson, Veikko Salomaa, Antti Jula, Olli T. Raitakari, Paul M Ridker, Aarno Palotie, Leena Peltonen, Matej Orešič,

Article2013

Genomic, Transcriptomic, and Lipidomic Profiling Highlights the Role of Inflammation in Individuals With Low High-density Lipoprotein Cholesterol

Pirkka‐Pekka Laurila, Ida Surakka, Antti‐Pekka Sarin, Laxman Yetukuri, Tuulia Hyötyläinen, Sanni Söderlund, Jussi Naukkarinen, Jing Tang, Johannes Kettunen, Daniel B. Mirel, Jarkko Soronen, Terho Lehtimäki, Aimo Ruokonen, Christian Ehnholm, Johan G. Eriksson, Veikko Salomaa, Antti Jula, Olli T. Raitakari, Paul M Ridker, Aarno Palotie, Leena Peltonen, Matej Orešič,

The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders

Discussion(0)

Related publications

Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese

Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease

Plasma high-density lipoprotein cholesterol but not apolipoprotein A-I is a good correlate of the visceral obesity—insulin resistance dyslipidemic syndrome

Genomic, Transcriptomic, and Lipidomic Profiling Highlights the Role of Inflammation in Individuals With Low High-density Lipoprotein Cholesterol

Genomic, Transcriptomic, and Lipidomic Profiling Highlights the Role of Inflammation in Individuals With Low High-density Lipoprotein Cholesterol